Understanding the impact of hospital transition to primary care and follow-up interventions

Project: Research

Project Details

Project Description

Survivors of stroke are at increased risk of subsequent vascular events, including recurrent stroke. Pharmacological interventions have been shown to prevent recurrent stroke within this high-risk population. Currently, measurement of adherence to secondary prevention medication are limited to cross-sectional studies at particular point in time from observational and clinical trials data.
Aims: To describe, in a nationally representative, large cohort of stroke survivors (n=25,000), long-term adherence and persistence with medications for secondary prevention; and to identify factors associated with adherence and persistence.
Methods: For the first time in Australia person-level linkages between Australian Stroke Clinical Registry(AuSCR) and Pharmaceutical data will be available. Adherence will be described in terms of non-adherence and poor persistence at 6 months (1-2 years), Patient, clinical, acute care system and community factors associated with adherence will be identified according to optimal care management at hospital discharge and in the community.
Significance: These data will provide essential evidence: to inform practice and policy; target quality improvement activities at the primary care level and develop interventions for improving adherence to secondary prevention medication. Primary health care providers(general practitioners, community pharmacists) and consumers(patients with stroke/TIA and carers) will be involved in the project to ensure results are immediately translatable. Total requested:$49,535
Effective start/end date1/01/1831/12/18


  • National Stroke Foundation (trading as Stroke Foundation): A$50,000.00